Elutia Inc. Class A Common Stock

ELUTNASDAQ • USD
ThemeMedical Devices & HealthTech›Orthopedic & Implantable Devices
1.07 USD
↘ 0.02 (1.83%)AT CLOSE (11:59 AM EDT)
1.08
↗ 0.00 (0.47%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1.08
↗ 0.00 (0.47%)
🔴Market: CLOSED
Open?$1.10
High?$1.10
Low?$1.06
Prev. Close?$1.09
Volume?22.1K
Avg. Volume?89.8K
VWAP?$1.07
Rel. Volume?0.25x
Bid / Ask
Bid?$0.90 × 100
Ask?$1.27 × 100
Spread?$0.37
Midpoint?$1.09
Valuation & Ratios
Market Cap?49.8M
Shares Out?44.2M
Float?32.2M
Float %?72.7%
P/E Ratio?0.93
P/B Ratio?1.80
EPS?$1.15
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.22Strong
Quick Ratio?2.12Strong
Cash Ratio?1.45Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
0.9CHEAP▾
P/B?
1.80CHEAP▾
P/S?
2.64CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
-0.7CHEAP▾
EV/Sales?
0.71CHEAP▾
Returns & Efficiency
ROE?
192.9%STRONG▾
ROA?
85.6%STRONG▾
Cash Flow & Enterprise
FCF?$-46686000
Enterprise Value?$13.5M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Employees
26
Market Cap
49.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.elutia.com
Listed
2020-10-08
Address
12510 PROSPERITY DRIVE
SILVER SPRING, MD 20904
Phone: 240-247-1143
MarketsMoversWatchlist